Shares in Immutep have leapt after the biotech reported phase 2b results showing that LAG-3 inhibitor eftilagimod alfa (efti) significantly boosted the efficacy of MSD’s Keytruda in patients ...

In this article, we are going to take a look at where Immutep Limited (NASDAQ:IMMP) stands against the other long term ASX stocks. Vanguard believes that Australia's economy remains well-placed to ...

Discover the Top 20 best Fashion Logos that define style in the industry! From iconic to innovative, explore how these logos captivate audiences! In fashion, logos are more than just symbols; they are ...

In a report released today, Elyse Shapiro from Canaccord Genuity maintained a Buy rating on Mayne Pharma Group (MAYNF – Research Report), with ...

We recently compiled a list of the 10 Best Long Term ASX Stocks to Buy Now. In this article, we are going to take a look at where Immutep Limited (NASDAQ:IMMP) stands against the other long term ASX ...

Late-stage clinical biotechnology company developing Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease.